scispace - formally typeset
Journal ArticleDOI

Comparison of acute effects of nifedipine in normotensive and hypertensive man.

TLDR
The results suggest that the contrasting BP response is caused mainly by a decreased sensitivity of the baroreceptor mechanism in arterial hypertension.
Abstract
Acute sublingual administration of nifedipine, 10 or 20 mg, caused a rapid dose-related decrease in blood pressure (BP) in hypertensive subjects (n = 17), whereas no significant reduction of blood pressure was observed in a group of normotensive subjects (n = 12). Forearm vascular resistance (CVR) decreased significantly in both groups (31.1 and 17.2%, respectively; inter-group difference nonsignificant). The vasodilatating effect of nifedipine tended to be stronger in hypertensives than in normotensives, as reflected by a higher CVR (%)/log plasma concentration of nifedipine index. A significant negative correlation was found between the change in CVR and the change in heart rate (HR) in normotensive subjects (r = −0.72, p < 0.05), whereas no such relationship was present in hypertensive patients. There was no significant correlation between the change in BP and the change in HR in any of the groups. The rise in plasma noradrenaline and resting HR did not differ significantly in hypertensive patients and in normotensive subjects receiving nifedipine 20 mg. The results suggest that the contrasting BP response is caused mainly by a decreased sensitivity of the baroreceptor mechanism in arterial hypertension. A larger decrease in CVR in hypertensive patients than in normotensive subjects could be due at least partly to morphological changes of the resistance vessels. However, a more marked relaxing effect of the calcium antagonist in hypertensive vessels than in normotensive vessels may have contributed to the observed difference in effect.

read more

Citations
More filters
Journal ArticleDOI

Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

TL;DR: Various sections of the manuscript reviewed by: U.H. Elkayam, Department of Medicine, University of Southern California, Los Angeles, California, USA, and H.R. Emanuelsson,Department of Medicine I,University of Goteborg, Gotesborg, Sweden.
Journal ArticleDOI

Nifedipine Kinetics and Bioavailability After Single Intravenous and Oral Doses in Normal Subjects

TL;DR: Evaluating the kinetics and bioavailability of nifedipine in 12 normal subjects after single intravenous and oral doses found profiles consistent with fast and slow absorption, with marked variability in the rate of appearance of the drug in plasma.
Journal ArticleDOI

Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders

TL;DR: In patients with mild to moderate essential hypertension nisoldipine monotherapy, in 1 or 2 daily doses, has maintained blood pressure control and has also been a useful addition to diuretics and beta-adrenoceptor blocking drugs in patients with poorly controlled disease.
Journal ArticleDOI

Newer Approaches to Antihypertensive Therapy: Use of Fixed-Dose Combination Therapy

TL;DR: The rationale for combination therapy relates to the concept that antihypertensive efficacy may be enhanced when 2 classes of agents are combined, and the possibility of enhancing salutary effects on target organs by combination therapy over and above the effects expected from the fall in arterial pressure alone.
Journal ArticleDOI

Hemodynamic and reflex responses to acute and chronic antihypertensive therapy with the calcium entry blocker nifedipine.

TL;DR: The depressor response to nifedipine is acutely, but not chronically, counteracted by baroreflex activation, and its magnitude is inversely related to the activity of the renin-angiotensin system, which suggests the potential by nifEDipine for effective antihypertensive monotherapy.
Related Papers (5)